Annual EBITDA
-$7.26 M
+$1.47 M+16.82%
31 December 2023
Summary:
ZIVO Bioscience annual earnings before interest, taxes, depreciation & amortization is currently -$7.26 million, with the most recent change of +$1.47 million (+16.82%) on 31 December 2023. During the last 3 years, it has risen by +$1.29 million (+15.11%). ZIVO annual EBITDA is now -694.65% below its all-time high of $1.22 million, reached on 31 December 2014.ZIVO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$2.26 M
+$5.97 M+72.54%
30 September 2024
Summary:
ZIVO Bioscience quarterly earnings before interest, taxes, depreciation & amortization is currently -$2.26 million, with the most recent change of +$5.97 million (+72.54%) on 30 September 2024. Over the past year, it has dropped by -$687.60 thousand (-43.73%). ZIVO quarterly EBITDA is now -155.01% below its all-time high of $4.11 million, reached on 31 March 2014.ZIVO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$13.66 M
-$687.60 K-5.30%
30 September 2024
Summary:
ZIVO Bioscience TTM earnings before interest, taxes, depreciation & amortization is currently -$13.66 million, with the most recent change of -$687.60 thousand (-5.30%) on 30 September 2024. Over the past year, it has dropped by -$5.66 million (-70.68%). ZIVO TTM EBITDA is now -1218.55% below its all-time high of $1.22 million, reached on 31 December 2014.ZIVO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZIVO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.8% | -43.7% | -70.7% |
| 3 y3 years | +15.1% | -45.7% | -91.4% |
| 5 y5 years | -11.1% | -43.6% | -120.0% |
ZIVO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +16.8% | -77.1% | +72.5% | -108.0% | at low |
| 5 y | 5 years | -11.1% | +16.8% | -119.4% | +72.5% | -120.0% | at low |
| alltime | all time | -694.6% | +24.3% | -155.0% | +72.5% | -1218.5% | at low |
ZIVO Bioscience EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.26 M(-72.5%) | -$13.66 M(+5.3%) |
| June 2024 | - | -$8.23 M(+545.1%) | -$12.97 M(+97.5%) |
| Mar 2024 | - | -$1.28 M(-32.7%) | -$6.57 M(-9.6%) |
| Dec 2023 | -$7.26 M(-16.8%) | -$1.90 M(+20.6%) | -$7.26 M(-9.3%) |
| Sept 2023 | - | -$1.57 M(-13.8%) | -$8.00 M(-5.1%) |
| June 2023 | - | -$1.82 M(-7.4%) | -$8.43 M(-2.8%) |
| Mar 2023 | - | -$1.97 M(-25.3%) | -$8.68 M(-0.6%) |
| Dec 2022 | -$8.73 M(+2.5%) | -$2.64 M(+31.9%) | -$8.73 M(-6.7%) |
| Sept 2022 | - | -$2.00 M(-3.3%) | -$9.36 M(+5.0%) |
| June 2022 | - | -$2.07 M(+2.0%) | -$8.91 M(+3.7%) |
| Mar 2022 | - | -$2.03 M(-37.9%) | -$8.59 M(-0.7%) |
| Dec 2021 | -$8.52 M(-0.4%) | -$3.26 M(+110.4%) | -$8.65 M(+21.1%) |
| Sept 2021 | - | -$1.55 M(-11.3%) | -$7.14 M(-20.3%) |
| June 2021 | - | -$1.75 M(-16.0%) | -$8.95 M(+8.7%) |
| Mar 2021 | - | -$2.08 M(+18.7%) | -$8.23 M(-3.8%) |
| Dec 2020 | -$8.56 M(+2.4%) | -$1.75 M(-47.8%) | -$8.56 M(-19.1%) |
| Sept 2020 | - | -$3.36 M(+226.7%) | -$10.57 M(+20.4%) |
| June 2020 | - | -$1.03 M(-57.2%) | -$8.78 M(-10.3%) |
| Mar 2020 | - | -$2.41 M(-36.2%) | -$9.79 M(+17.2%) |
| Dec 2019 | -$8.35 M(+27.7%) | -$3.77 M(+139.7%) | -$8.35 M(+34.5%) |
| Sept 2019 | - | -$1.57 M(-22.7%) | -$6.21 M(+1.1%) |
| June 2019 | - | -$2.04 M(+110.5%) | -$6.14 M(+11.1%) |
| Mar 2019 | - | -$967.90 K(-40.6%) | -$5.53 M(-15.4%) |
| Dec 2018 | -$6.54 M(-7.5%) | -$1.63 M(+8.1%) | -$6.54 M(-13.4%) |
| Sept 2018 | - | -$1.51 M(+5.8%) | -$7.55 M(-9.2%) |
| June 2018 | - | -$1.43 M(-27.8%) | -$8.31 M(+7.1%) |
| Mar 2018 | - | -$1.97 M(-25.3%) | -$7.76 M(+9.4%) |
| Dec 2017 | -$7.07 M(+42.1%) | -$2.64 M(+16.3%) | -$7.10 M(+33.3%) |
| Sept 2017 | - | -$2.27 M(+159.6%) | -$5.33 M(+35.1%) |
| June 2017 | - | -$875.20 K(-33.2%) | -$3.94 M(-23.0%) |
| Mar 2017 | - | -$1.31 M(+50.5%) | -$5.12 M(+2.9%) |
| Dec 2016 | -$4.98 M(-1.3%) | -$870.00 K(-1.9%) | -$4.98 M(+1.4%) |
| Sept 2016 | - | -$886.60 K(-56.8%) | -$4.91 M(-7.4%) |
| June 2016 | - | -$2.05 M(+76.1%) | -$5.30 M(+4.3%) |
| Mar 2016 | - | -$1.17 M(+45.9%) | -$5.08 M(+0.7%) |
| Dec 2015 | -$5.04 M(-512.9%) | -$799.30 K(-37.6%) | -$5.04 M(+49.2%) |
| Sept 2015 | - | -$1.28 M(-30.2%) | -$3.38 M(-36.1%) |
| June 2015 | - | -$1.83 M(+62.5%) | -$5.29 M(+31.6%) |
| Mar 2015 | - | -$1.13 M(-230.6%) | -$4.02 M(-428.8%) |
| Dec 2014 | $1.22 M(-112.7%) | $864.50 K(-127.1%) | $1.22 M(+36.3%) |
| Sept 2014 | - | -$3.19 M(+463.4%) | $896.00 K(-277.5%) |
| June 2014 | - | -$565.50 K(-113.8%) | -$504.80 K(-75.8%) |
| Mar 2014 | - | $4.11 M(+662.1%) | -$2.09 M(-70.3%) |
| Dec 2013 | -$9.60 M(+340.0%) | $539.10 K(-111.8%) | -$7.03 M(-6.8%) |
| Sept 2013 | - | -$4.59 M(+113.4%) | -$7.54 M(+117.9%) |
| June 2013 | - | -$2.15 M(+159.2%) | -$3.46 M(+136.6%) |
| Mar 2013 | - | -$829.20 K(-3277.0%) | -$1.46 M(+8.3%) |
| Dec 2012 | -$2.18 M | $26.10 K(-105.1%) | -$1.35 M(-45.1%) |
| Sept 2012 | - | -$507.20 K(+233.7%) | -$2.46 M(+11.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | -$152.00 K(-78.8%) | -$2.20 M(-4.5%) |
| Mar 2012 | - | -$717.50 K(-33.7%) | -$2.31 M(+14.8%) |
| Dec 2011 | -$2.01 M(-50.1%) | -$1.08 M(+334.0%) | -$2.01 M(+22.3%) |
| Sept 2011 | - | -$249.40 K(-2.5%) | -$1.64 M(-15.0%) |
| June 2011 | - | -$255.70 K(-39.2%) | -$1.93 M(-44.6%) |
| Mar 2011 | - | -$420.30 K(-41.3%) | -$3.49 M(-13.3%) |
| Dec 2010 | -$4.02 M(+53.6%) | -$716.20 K(+32.9%) | -$4.02 M(-2.5%) |
| Sept 2010 | - | -$539.00 K(-70.2%) | -$4.12 M(-9.5%) |
| June 2010 | - | -$1.81 M(+89.3%) | -$4.56 M(+49.3%) |
| Mar 2010 | - | -$956.90 K(+17.1%) | -$3.06 M(+16.6%) |
| Dec 2009 | -$2.62 M(+122.7%) | -$817.40 K(-16.1%) | -$2.62 M(+29.4%) |
| Sept 2009 | - | -$974.30 K(+217.9%) | -$2.02 M(+59.5%) |
| June 2009 | - | -$306.50 K(-41.2%) | -$1.27 M(-6.8%) |
| Mar 2009 | - | -$521.60 K(+135.4%) | -$1.36 M(+92.9%) |
| Dec 2008 | -$1.18 M(-44.6%) | -$221.60 K(+1.0%) | -$706.20 K(-16.6%) |
| Sept 2008 | - | -$219.40 K(-45.1%) | -$846.30 K(-34.7%) |
| June 2008 | - | -$399.50 K(-397.5%) | -$1.30 M(-4.3%) |
| Mar 2008 | - | $134.30 K(-137.1%) | -$1.35 M(-36.2%) |
| Dec 2007 | -$2.12 M(-33.8%) | -$361.70 K(-45.9%) | -$2.12 M(-3.1%) |
| Sept 2007 | - | -$668.40 K(+46.0%) | -$2.19 M(+1.2%) |
| June 2007 | - | -$457.90 K(-27.8%) | -$2.16 M(-25.3%) |
| Mar 2007 | - | -$633.80 K(+47.9%) | -$2.89 M(-1.7%) |
| Dec 2006 | -$3.21 M(+17.4%) | -$428.60 K(-33.2%) | -$2.94 M(-3.8%) |
| Sept 2006 | - | -$641.50 K(-46.1%) | -$3.06 M(-24.1%) |
| June 2006 | - | -$1.19 M(+73.6%) | -$4.03 M(+26.5%) |
| Mar 2006 | - | -$685.20 K(+25.8%) | -$3.19 M(+13.2%) |
| Dec 2005 | -$2.73 M(-28.9%) | -$544.60 K(-66.2%) | -$2.82 M(+0.2%) |
| Sept 2005 | - | -$1.61 M(+365.1%) | -$2.81 M(+30.8%) |
| June 2005 | - | -$346.50 K(+10.6%) | -$2.15 M(-15.4%) |
| Mar 2005 | - | -$313.30 K(-42.0%) | -$2.54 M(-33.8%) |
| Dec 2004 | -$3.84 M(+610.5%) | -$540.00 K(-43.2%) | -$3.84 M(+0.1%) |
| Sept 2004 | - | -$950.10 K(+28.5%) | -$3.84 M(+32.8%) |
| June 2004 | - | -$739.10 K(-54.2%) | -$2.89 M(+34.3%) |
| Mar 2004 | - | -$1.61 M(+199.9%) | -$2.15 M(+297.9%) |
| Dec 2003 | -$540.80 K(>+9900.0%) | -$537.80 K(>+9900.0%) | -$540.90 K(>+9900.0%) |
| Sept 2003 | - | -$600.00(0.0%) | -$3700.00(0.0%) |
| June 2003 | - | -$600.00(-68.4%) | -$3700.00(0.0%) |
| Mar 2003 | - | -$1900.00(+216.7%) | -$3700.00(+8.8%) |
| Dec 2002 | -$3400.00(+61.9%) | -$600.00(0.0%) | -$3400.00(0.0%) |
| Sept 2002 | - | -$600.00(0.0%) | -$3400.00(0.0%) |
| June 2002 | - | -$600.00(-62.5%) | -$3400.00(0.0%) |
| Mar 2002 | - | -$1600.00(+166.7%) | -$3400.00(+70.0%) |
| Dec 2001 | -$2100.00(-41.7%) | -$600.00(0.0%) | -$2000.00(-54.5%) |
| Sept 2001 | - | -$600.00(0.0%) | -$4400.00(0.0%) |
| June 2001 | - | -$600.00(+200.0%) | -$4400.00(+15.8%) |
| Mar 2001 | - | -$200.00(-93.3%) | -$3800.00(+5.6%) |
| Dec 2000 | -$3600.00 | -$3000.00(+400.0%) | -$3600.00(+500.0%) |
| Sept 2000 | - | -$600.00(-96.1%) | -$600.00(-96.1%) |
| Sept 1999 | - | -$15.20 K | -$15.20 K |
FAQ
- What is ZIVO Bioscience annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for ZIVO Bioscience?
- What is ZIVO Bioscience annual EBITDA year-on-year change?
- What is ZIVO Bioscience quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly EBITDA year-on-year change?
- What is ZIVO Bioscience TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for ZIVO Bioscience?
- What is ZIVO Bioscience TTM EBITDA year-on-year change?
What is ZIVO Bioscience annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ZIVO is -$7.26 M
What is the all time high annual EBITDA for ZIVO Bioscience?
ZIVO Bioscience all-time high annual earnings before interest, taxes, depreciation & amortization is $1.22 M
What is ZIVO Bioscience annual EBITDA year-on-year change?
Over the past year, ZIVO annual earnings before interest, taxes, depreciation & amortization has changed by +$1.47 M (+16.82%)
What is ZIVO Bioscience quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ZIVO is -$2.26 M
What is the all time high quarterly EBITDA for ZIVO Bioscience?
ZIVO Bioscience all-time high quarterly earnings before interest, taxes, depreciation & amortization is $4.11 M
What is ZIVO Bioscience quarterly EBITDA year-on-year change?
Over the past year, ZIVO quarterly earnings before interest, taxes, depreciation & amortization has changed by -$687.60 K (-43.73%)
What is ZIVO Bioscience TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ZIVO is -$13.66 M
What is the all time high TTM EBITDA for ZIVO Bioscience?
ZIVO Bioscience all-time high TTM earnings before interest, taxes, depreciation & amortization is $1.22 M
What is ZIVO Bioscience TTM EBITDA year-on-year change?
Over the past year, ZIVO TTM earnings before interest, taxes, depreciation & amortization has changed by -$5.66 M (-70.68%)